NASDAQ NMS - GLOBAL MARKET · JBIO

0.00% · $0.0000 · Vol Not reported

Market closed · last close shown

Jade Biosciences Inc

Biotechnology

$14.15

Card

Relationship Map

Follow $JBIO

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $JBIO by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measured

Stale score · Wed Oct 7 · completed session · 38h old · Scheduled each trading day · Pre-market · regular session opens 9:30 ET · JBIO

Methodology

Thu Oct 8 snapshot unavailable for JBIO. Cause unavailable.

JBIO

Jade Biosciences Inc

Stale score · Wed Oct 7 · completed session · 38h old · Scheduled each trading day · Pre-market · regular session opens 9:30 ET

55/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

55/ 100

Veridion Score

Middle range · MEDIUM confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 6 of 6 factors measured · Stale score · Wed Oct 7 · completed session · 38h old · Scheduled each trading day · Pre-market · regular session opens 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is JBIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move JBIO next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Oct 7
Score
Score moved +5
50/Middle range -> 55/Middle range
Veridion score historySource

About Jade Biosciences Inc

PHARMACEUTICAL PREPARATIONS

Listed since

2025

Employees

Country

Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$14.15

Last session

Day high

$14.15

Last session

Day low

$14.15

Last session

Previous close

$14.15

52W high

$26.85

-47.30% from high

52W low

$8.95

29% of range

Market cap

$899.9M

EPS

$-1.9200

Beta

0.45

Shares out

63.6M

Avg volume

959.9K

VWAP

$14.15

Last session

Price history computed in-house

+0.21%

-25.76%

-32.46%

+50.53%

YTD

-8.30%

SMA 50 $18.99 · below

SMA 200 $18.28 · below

52W position 29%

JBIO overview

Veridion Score

Registered · 2026-10-07

6 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around JBIO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

JBIO insider activity

Jade Biosciences Inc

90 days, by filing date. Snapshot as of 2026-10-08T23:29:28.642Z.

Score

Not evaluated

Pressure

Not evaluated

Transactions

Unavailable

Filings

Unavailable

Buys / sells

Unavailable

Net value

Not evaluated

Insiders

Unavailable

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in JBIO

Congress tracker Open ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

JBIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for JBIO in this window.

Lobbying spend

JBIO lobbying filings, year to date.

Registered lobbying filings matched to Jade Biosciences Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for JBIO in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for JBIO.

Options

Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $JBIO

Why is JBIO moving today?

What can move JBIO next.

JBIO overview

Related filings and maps

JBIO insider activity

JBIO contract awards, year to date.

JBIO lobbying filings, year to date.

Cross-references from this score page.

What can move JBIO next.

JBIO insider activity

Cross-references from this score page.